Eli Lilly outlays $2.3bn to acquire blood cancer specialist Ajax Therapeutics
Eli Lilly has added yet another string to its M&A bow of 2026 after agreeing to acquire cancer specialist Ajax…
News
Novartis secures pair of regulatory wins for skin disease and malaria treatments
UK biotech could be bound for recovery, BIA report reveals
Sun Pharma to acquire Organon for $11.75bn
Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings
OZMOSI and Planview partner to enhance pharmaceutical data integration
Regeneron cuts White House pricing deal, offers new gene therapy for free
Cumberland to sell drug portfolio to Apotex for $100m
